ArticleESMO gastrointestinal oncology2026
A prospective, multicenter, observational study of trastuzumab deruxtecan in elderly patients with HER2-positive gastric cancer: EN-COURAGE.
Y Narita et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.